Champions Oncology Inc (CSBR) CEO Joel Ackerman Buys 8,202 Shares of Stock
Champions Oncology Inc (OTCMKTS:CSBR) CEO Joel Ackerman acquired 8,202 shares of Champions Oncology stock in a transaction dated Friday, October 7th. The shares were acquired at an average price of $1.63 per share, with a total value of $13,369.26. Following the completion of the acquisition, the chief executive officer now directly owns 1,027,764 shares of the company’s stock, valued at $1,675,255.32. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
Joel Ackerman also recently made the following trade(s):
- On Friday, September 23rd, Joel Ackerman acquired 33 shares of Champions Oncology stock. The shares were acquired at an average price of $1.65 per share, with a total value of $54.45.
- On Wednesday, September 21st, Joel Ackerman acquired 5,000 shares of Champions Oncology stock. The shares were acquired at an average price of $1.66 per share, with a total value of $8,300.00.
Champions Oncology Inc (OTCMKTS:CSBR) opened at 1.65 on Monday. Champions Oncology Inc has a 12-month low of $1.11 and a 12-month high of $5.49. The stock’s market capitalization is $18.10 million. The company’s 50-day moving average is $1.69 and its 200 day moving average is $2.62.
Champions Oncology (OTCMKTS:CSBR) last announced its quarterly earnings results on Friday, September 9th. The company reported ($0.15) earnings per share for the quarter. The business had revenue of $3.70 million for the quarter.
Champions Oncology Company Profile
Champions Oncology, Inc is engaged in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The Company has two business segments: Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). The POS segment provides physicians and patients information to help guide the development of personalized treatment plans.
Receive News & Ratings for Champions Oncology Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Champions Oncology Inc and related companies with MarketBeat.com's FREE daily email newsletter.